On March 30, 2026, Allied Gaming & Entertainment Inc. reported the resignations of Mr. Yushi Guo and Mr. Jerry Qin from its Board of Directors and all committees. Following these departures, the Board reconstituted its committees. The Audit Committee now comprises Mao Sun, Jingsheng Lu, and Yuanfei Qu. The Compensation...

Arcadia Biosciences, Inc. has dismissed Deloitte & Touche LLP as its independent registered public accounting firm, effective March 30, 2026. The dismissal was approved by the company's audit committee. Deloitte's audit reports for the years ended December 31, 2025, and 2024, did not contain adverse opinions or disclai...

Arrive AI Inc. has been notified by Nasdaq that it is not in compliance with the minimum Market Value of Publicly Held Shares (MVPHS) and minimum Market Value of Listed Securities (MVLS) requirements for continued listing on The Nasdaq Global Market. The company failed to meet the MVPHS requirement of $15,000,000 for 3...

On March 30, 2026, Aurinia Pharmaceuticals Inc. (Aurinia) announced a definitive agreement to acquire Kezar Life Sciences, Inc. (Kezar) through a tender offer. Under the terms of the agreement, Aurinia will pay $6.955 per share in cash plus one Contingent Value Right (CVR) per share. The CVR entitles Kezar stockholders...

Battalion Oil Corporation reported on March 30, 2026, that David Chang resigned from the Board of Directors, including his role as Chairman of the Compensation Committee, effective March 31, 2026. Concurrently, Ajay Jegadeesan resigned from the Board. Both directors stated their resignations were not due to any disagre...

BK Technologies Corporation held an Investor Day on April 2, 2026, discussing their Vision 2030 objectives. The company aims to double revenue to $170 million by 2030, increase gross margin to 60%, and expand EBITDA margin to 35%. This growth will be driven by new products like the BKR9500 mobile radio (launching H1 20...

Bloomia Holdings, Inc. announced the preliminary results of its rights offering, which commenced in February 2026 and expired on April 1, 2026. The offering is expected to yield approximately $12.1 million in gross proceeds, comprising $5 million in cash and $7.1 million from the conversion of outstanding debt. A total...

BT Brands, Inc. filed a Form 8-K on March 30, 2026, announcing its financial results for the fourth quarter and fiscal year ended December 28, 2025. The company, which trades on the Nasdaq Capital Market under symbols BTBD (common stock) and BTBDW (warrants), issued a press release detailing its operational and financi...

On March 31, 2026, BlackRock, Inc. entered into Amendment No. 17 to its Five-Year Revolving Credit Agreement. This amendment increases the revolving facility commitments by $400,000,000 to a total of $6,300,000,000 and extends the maturity date to March 31, 2031 for most lenders. A portion of the commitments from two n...

On April 1, 2026, Bluerock Homes Trust, Inc. issued 108,699 long-term incentive plan units (LTIP Units) in its operating partnership and 84,055 shares of Class A common stock as restricted stock grants. These grants were awarded to certain employees of the manager and personnel providing services to the manager, as an ...

On March 31, 2026, Ashford Inc. and Ashford Hospitality Advisors LLC (the "Advisor") provided written notice to Braemar Hotels & Resorts Inc. of their election to extend the term of the Fifth Amended and Restated Advisory Agreement. The extension, exercised under Section 12.2 of the agreement, grants an additional ten-...

Daniel Schurr resigned from the CHS Inc. Board of Directors on March 30, 2026, due to accepting a position on the board of directors of Nationwide Mutual Insurance Company. Schurr had been a director since 2006 and served as Chair from 2017 to December 2025. He represented Region 7. A replacement will be elected by CHS...

Citigroup Inc. has filed a Form 8-K to disclose reporting changes for the first quarter of 2026. These changes include the transfer of the Retail Banking business from U.S. Personal Banking (USPB) to Wealth, and the integration of remaining USPB businesses into a new U.S. Consumer Cards segment. Financial results, bala...

This filing details a transition in leadership at ClearOne, Inc. as of April 1, 2026. Derek L. Graham, the former CEO, will continue to serve the company on a transitional basis. He will provide consulting services for up to ten hours per week at a rate of $160 per hour, while still performing all CEO functions. This a...

This Form 8-K filing for Credit Acceptance Corporation details their business operations and financial performance as of April 3, 2026. The company focuses on maximizing long-term intrinsic value per share by enabling dealers to serve consumers regardless of credit history. They are investing in technology, including A...

CitroTech Inc. has entered into a Transition Agreement with its Chief Technology Officer, Stephen Conboy. effective March 31, 2026. Mr. Conboy will transition from his role as CTO to an outside advisor to the CEO for a 90-day period ending June 30, 2026. During this period, he will assist in transitioning relationships...

On April 1, 2026, Climb Bio, Inc. announced that Cindy Driscoll, the Senior Vice President of Finance and principal accounting officer, will separate from the company effective April 30, 2026. This departure was described as a mutual agreement between Ms. Driscoll and the company. Following her departure, Dr. Susan Alt...

Crown Reserve Acquisition Corp. I (SPAC) and Carvix, Inc. have entered into a Business Combination Agreement. The agreement outlines a transaction structure involving a domestication of the SPAC to Delaware, followed by a merger of a SPAC subsidiary with Carvix. Carvix will survive as a wholly-owned subsidiary of the d...

On April 2, 2026, Datasea Inc. held a special meeting of stockholders to vote on two proposals. The first proposal was to approve and adopt the Merger Agreement and Plan of Merger between Datasea Inc. and its wholly owned subsidiary, Datasea Intelligent Technology Ltd. (DIT). This merger will result in the Company merg...

On March 30, 2026, Jeff Haywood resigned from the Board of Directors of Definitive Healthcare Corp. and as a member of the Human Capital Management and Compensation Committee, effective immediately. The resignation was not due to any disagreements with the company regarding its operations, policies, or practices. Follo...

On April 3, 2026, Denali Therapeutics announced that it has regained full global rights to DNL593 (PTV:PGRN) following the termination of its collaboration agreement with Takeda Pharmaceutical Company. Takeda's decision to terminate the 2018 agreement was based on strategic considerations and was not related to any saf...

Drugs Made In America Acquisition II Corp. has entered into a Definitive Investment and Sponsor Transition Agreement with Alpha Multi Family Office for a $1.4 million convertible notes financing. This agreement supersedes prior understandings and outlines the terms of the investment. A portion of the funds, $150,000, h...

EACO Corporation announced its financial results for the second quarter of fiscal year 2026, ending February 28, 2026. The company reported record net sales of $117,836,000, a 17.7% increase compared to the same period in the previous year. Net income also reached an all-time quarterly record of $9,797,000, marking a 4...

J. Mark Hemmann has resigned from his position as a member of the Board of Directors of ESG Inc. and all committees of the Board, effective March 31, 2026. His resignation was not due to any disagreements with the Company regarding its operations, policies, or practices. To fill the vacancy, the remaining Board members...

On April 3, 2026, Ensysce Biosciences, Inc. reported that Dr. Curtis Rosebraugh resigned from the company's Board of Directors, effective April 1, 2026. Prior to his resignation, Dr. Rosebraugh served as a member of the Nominating and Corporate Governance Committee. According to the resignation notice filed as Exhibit ...